Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Lexington › NPI 1538244918
Hospital

Baptist Healthcare System, INC

Baptist Healthcare System, INC was paid $98.07M by Medicaid between Jan 2018 and Dec 2024, across 536 billing codes. Its largest line is 99284, emergency room visit (serious) — 7.2% of everything it billed.

33Billing provider infoBAPTIST HEALTHCARE SYSTEM, INC
LEXINGTON, KY 40503
33aNPI1538244918assigned 10/26/2006
28Total paid$98.07M
24GClaims2,179,531
24DCodes billed536
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Kentucky

Rank by total paid#5 of 36
Median peer was paid$36.08M
This provider vs. median2.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official CARRICO, RICHARD controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018232,439$9.76M
2019241,876$10.68M
2020267,505$13.16M
2021340,179$15.59M
2022348,198$13.72M
2023395,646$16.47M
2024incomplete353,688$18.69M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 7.2% 28,447 23,795 $7.06M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.2% 42,903 36,939 $7.02M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.5% 10,628 9,434 $4.38M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 3.6% 8,702 7,825 $3.53M
93458 3.4% 3,288 1,384 $3.35M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.3% 9,976 7,109 $3.28M
G0378 Hospital observation service, per hour 3.1% 9,555 7,406 $3.00M
74176 Computed tomography, abdomen and pelvis; without contrast material 2.7% 7,512 6,703 $2.67M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2.4% 6,207 3,320 $2.35M
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 2.1% 4,343 2,131 $2.06M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 15,467 8,852 $1.87M
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 1.9% 28,526 25,447 $1.82M
524 more codes
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 1.8% 1,184 $1.80M
96375 Therapeutic injection; each additional sequential IV push 1.5% 27,864 $1.51M
70450 Computed tomography, head or brain; without contrast material 1.4% 7,451 $1.40M
80053 Comprehensive metabolic panel 1.3% 144,228 $1.31M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 1.2% 4,138 $1.21M
71275 Computed tomographic angiography, chest, with contrast material 1.2% 5,040 $1.18M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 38,322 $1.10M
93017 1.1% 4,105 $1.04M
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 18,706 $963K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 36,803 $919K
95886 <1% 3,052 $885K
70551 Magnetic resonance imaging, brain; without contrast material <1% 3,364 $856K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 7,881 $780K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 3,581 $757K
77067 Screening mammography, bilateral, including computer-aided detection <1% 8,904 $718K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 6,825 $706K
36415 Collection of venous blood by venipuncture <1% 147,778 $697K
96361 Intravenous infusion, hydration; each additional hour <1% 9,945 $683K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 10,040 $678K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 97,458 $675K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,426 $659K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 19,746 $657K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 3,410 $656K
80050 General health panel <1% 17,262 $634K
84443 Thyroid stimulating hormone (TSH) <1% 42,156 $624K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 4,749 $598K
59025 Fetal non-stress test <1% 6,471 $581K
71045 Radiologic examination, chest; single view <1% 20,748 $573K
96376 <1% 8,985 $553K
74178 <1% 742 $544K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 22,474 $534K
71250 <1% 3,572 $531K
80061 Lipid panel <1% 43,765 $528K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 11,470 $482K
76819 Fetal biophysical profile; without non-stress testing <1% 5,783 $474K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 6,455 $466K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,722 $438K
C1769 Guide wire <1% 3,365 $432K
96367 <1% 3,947 $416K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,342 $416K
83880 <1% 12,728 $400K
76642 <1% 4,332 $395K
97597 <1% 3,667 $395K
72141 <1% 1,471 $390K
93971 <1% 2,170 $373K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 929 $364K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 10,325 $354K
71046 Radiologic examination, chest; 2 views <1% 11,871 $346K
78815 Positron emission tomography (PET) for limited area imaging <1% 801 $337K
96415 <1% 1,703 $336K
77066 Tomosynthesis, mammo <1% 4,150 $331K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 4,538 $323K
80081 <1% 4,480 $313K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 697 $295K
95910 <1% 860 $289K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,102 $284K
J2785 Injection, regadenoson, 0.1 mg <1% 1,728 $278K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 25,482 $273K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 10,017 $271K
72125 Computed tomography, cervical spine; without contrast material <1% 1,337 $266K
73560 <1% 3,414 $266K
72100 <1% 3,454 $258K
77300 <1% 427 $254K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 5,474 $254K
83036 Hemoglobin; glycosylated (A1C) <1% 31,982 $253K
73221 <1% 874 $245K
73630 <1% 2,783 $239K
82607 <1% 17,911 $237K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,664 $235K
84484 <1% 24,465 $230K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 1,713 $229K
73030 <1% 2,999 $228K
85027 <1% 35,661 $222K
76775 <1% 1,266 $221K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 8,863 $220K
58571 <1% 161 $214K
86803 <1% 16,723 $207K
76536 <1% 2,134 $206K
77336 <1% 1,864 $205K
87086 Culture, bacterial; quantitative colony count, urine <1% 26,640 $203K
72040 <1% 2,296 $202K
70496 <1% 914 $199K
C1776 Joint device (implantable) <1% 46 $196K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 3,363 $189K
73610 <1% 2,297 $183K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 3,612 $180K
80048 Basic metabolic panel (calcium, ionized) <1% 21,909 $179K
74018 <1% 2,737 $176K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,855 $175K
77065 Tomosynthesis, mammo <1% 2,444 $173K
73130 <1% 1,848 $173K
76830 Ultrasound, transvaginal <1% 2,001 $170K
84439 <1% 19,907 $166K
93325 <1% 1,853 $166K
J7050 Infusion, normal saline solution, 250 cc <1% 3,630 $162K
70498 <1% 793 $159K
84702 <1% 11,484 $158K
97161 <1% 5,198 $155K
72110 <1% 997 $152K
72131 <1% 694 $152K
83690 <1% 26,478 $151K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 16,339 $150K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,875 $144K
80074 <1% 3,610 $143K
93880 <1% 1,033 $142K
74240 <1% 665 $142K
76820 <1% 3,280 $141K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,736 $137K
80306 <1% 9,384 $136K
87507 <1% 480 $134K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 5,768 $128K
88307 <1% 2,154 $125K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,604 $125K
J3490 Unclassified drugs <1% 1,280 $124K
93970 <1% 536 $120K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 8,806 $118K
G0432 Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening <1% 7,704 $117K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 401 $114K
C1889 Implantable/insertable device, not otherwise classified <1% 875 $107K
73502 <1% 1,828 $107K
73110 <1% 1,160 $105K
81001 <1% 32,723 $103K
93976 <1% 822 $101K
82728 <1% 8,197 $101K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,203 $100K
75574 <1% 305 $100K
81025 <1% 18,175 $97K
82746 <1% 7,685 $95K
84466 <1% 8,273 $91K
87522 Neg quan hep c or qual rna <1% 2,385 $90K
83605 <1% 10,381 $89K
82962 <1% 17,338 $87K
78431 <1% 522 $87K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 919 $86K
84112 <1% 980 $84K
96417 <1% 665 $84K
95806 <1% 565 $84K
77290 <1% 340 $82K
83735 <1% 14,027 $81K
84403 <1% 3,551 $77K
84145 <1% 3,869 $77K
78264 <1% 214 $77K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 804 $76K
86850 <1% 9,426 $76K
71271 <1% 1,188 $72K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 14,775 $69K
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 767 $69K
72156 <1% 181 $69K
76825 <1% 794 $68K
77063 Screening digital breast tomosynthesis, bilateral <1% 10,346 $66K
70486 <1% 300 $63K
77280 <1% 303 $62K
83540 <1% 10,787 $62K
87186 <1% 7,916 $60K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,131 $59K
82670 <1% 2,352 $59K
87040 <1% 7,318 $59K
0100U <1% 292 $58K
97162 <1% 2,187 $57K
86480 <1% 1,068 $56K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,614 $55K
87070 <1% 6,999 $55K
C1887 Catheter, guiding (may include infusion/perfusion capability) <1% 555 $54K
83001 <1% 3,259 $53K
86235 <1% 635 $51K
72072 <1% 550 $51K
83013 <1% 827 $51K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 4,376 $50K
82948 <1% 6,620 $50K
87081 <1% 7,439 $49K
84144 <1% 2,699 $48K
C1760 Closure device, vascular (implantable/insertable) <1% 172 $48K
C1874 Stent, coated/covered, with delivery system <1% 34 $47K
19083 <1% 43 $47K
72158 <1% 123 $47K
86140 <1% 10,699 $47K
85610 <1% 12,109 $46K
77080 <1% 930 $45K
74241 <1% 230 $45K
86038 <1% 4,201 $45K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 72 $45K
84402 <1% 2,110 $45K
88342 <1% 1,438 $44K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 892 $44K
82805 <1% 891 $44K
J1170 Injection, hydromorphone, up to 4 mg <1% 10,994 $44K
82784 <1% 3,008 $43K
87340 <1% 4,928 $43K
81003 <1% 17,838 $43K
95911 <1% 120 $42K
78227 <1% 111 $42K
85379 <1% 4,797 $41K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,942 $41K
87077 <1% 5,215 $41K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 2,452 $40K
J2704 Injection, propofol, 10 mg <1% 11,267 $38K
84146 <1% 2,296 $38K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,971 $38K
A4648 Tissue marker, implantable, any type, each <1% 322 $37K
99152 <1% 932 $37K
93613 <1% 15 $36K
82077 <1% 2,928 $35K
88304 <1% 1,452 $35K
70491 <1% 152 $34K
83002 <1% 2,132 $34K
93246 <1% 976 $34K
0042T <1% 110 $33K
87529 <1% 899 $32K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,216 $32K
97165 <1% 1,191 $31K
J7030 Infusion, normal saline solution , 1000 cc <1% 7,723 $31K
84481 <1% 1,902 $31K
73562 <1% 321 $31K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,189 $30K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 40 $30K
82043 <1% 5,636 $28K
83516 <1% 1,630 $28K
82247 <1% 4,745 $28K
0002A <1% 1,018 $27K
83615 <1% 4,650 $27K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,353 $26K
76801 <1% 314 $26K
86901 <1% 8,039 $26K
76885 <1% 243 $26K
87147 <1% 3,483 $25K
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,705 $25K
86900 <1% 8,156 $25K
0001A <1% 1,117 $25K
84550 <1% 6,145 $24K
85730 <1% 3,911 $24K
76870 <1% 288 $23K
82570 <1% 5,177 $23K
82550 <1% 3,751 $23K
87205 <1% 6,057 $23K
94010 <1% 394 $23K
47562 <1% 12 $22K
86592 <1% 5,322 $22K
95816 <1% 79 $22K
83970 <1% 625 $22K
85652 <1% 9,029 $22K
86696 <1% 1,240 $21K
94729 <1% 634 $21K
86376 <1% 1,660 $21K
78492 <1% 62 $21K
86780 <1% 1,951 $21K
86706 <1% 2,172 $20K
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,036 $20K
A9541 Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries <1% 165 $20K
84132 <1% 4,383 $20K
97535 Self-care/home management training, each 15 minutes <1% 1,237 $19K
82950 <1% 5,790 $19K
36591 <1% 1,074 $19K
86762 <1% 1,561 $19K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 5,591 $19K
82565 <1% 3,569 $18K
C1732 Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping <1% 16 $18K
94664 <1% 715 $18K
77412 <1% 108 $18K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 25,976 $18K
97116 <1% 1,565 $17K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 6,440 $17K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 1,086 $17K
87493 <1% 592 $17K
82627 <1% 813 $17K
74455 <1% 76 $17K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 2,798 $17K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 13,462 $16K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 13,754 $16K
86704 <1% 1,500 $16K
84450 <1% 3,503 $16K
84460 <1% 3,528 $16K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 2,026 $15K
J1644 Injection, heparin sodium, per 1000 units <1% 7,320 $15K
86695 <1% 1,176 $15K
86431 <1% 2,747 $15K
84075 <1% 3,114 $15K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 571 $15K
80047 <1% 1,643 $15K
99153 Mod sedat endo service >5yrs <1% 169 $14K
80143 <1% 891 $14K
73590 <1% 187 $14K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 976 $14K
84165 <1% 835 $13K
86003 <1% 151 $13K
82533 <1% 929 $13K
86364 <1% 1,000 $13K
86800 <1% 948 $13K
88341 <1% 180 $13K
84100 <1% 2,793 $12K
94727 <1% 345 $12K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 65 $12K
80179 <1% 836 $11K
87902 <1% 53 $11K
87641 <1% 404 $11K
87088 <1% 1,572 $11K
C1730 Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) <1% 33 $11K
36416 <1% 4,486 $11K
P9612 Catheterization for collection of specimen, single patient, all places of service <1% 2,242 $11K
74183 <1% 34 $11K
72132 <1% 48 $11K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 721 $11K
77334 <1% 16 $11K
94726 <1% 220 $10K
82947 <1% 3,021 $10K
J3411 Injection, thiamine hcl, 100 mg <1% 1,671 $10K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 59 $10K
76813 <1% 131 $10K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 14 $10K
94060 <1% 96 $10K
92523 <1% 162 $10K
93623 <1% 17 $10K
82150 <1% 1,517 $10K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 469 $9K
77049 <1% 29 $9K
86258 <1% 544 $9K
72120 <1% 114 $9K
83921 <1% 520 $9K
87481 <1% 271 $9K
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 122 $8K
86147 <1% 178 $8K
86231 <1% 859 $8K
86787 <1% 750 $8K
85014 <1% 3,933 $8K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,065 $8K
82248 <1% 1,792 $8K
82330 <1% 773 $8K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,906 $8K
80076 <1% 996 $8K
96368 <1% 100 $8K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 6,694 $7K
36430 <1% 21 $7K
88302 <1% 319 $7K
0097U <1% 50 $7K
86708 <1% 704 $7K
51600 <1% 76 $7K
83655 <1% 603 $7K
86334 <1% 259 $7K
85347 <1% 296 $7K
83520 <1% 420 $7K
84480 <1% 529 $7K
86255 <1% 504 $7K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,554 $7K
86225 <1% 552 $6K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 99 $6K
J1790 Injection, droperidol, up to 5 mg <1% 1,250 $6K
83550 <1% 694 $6K
86665 <1% 173 $6K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,137 $6K
81374 <1% 98 $6K
73070 <1% 91 $6K
78226 <1% 20 $6K
83498 <1% 247 $6K
P9016 Red blood cells, leukocytes reduced, each unit <1% 21 $6K
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 3,264 $5K
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,308 $5K
84445 <1% 122 $5K
82951 <1% 511 $5K
J2805 Injection, sincalide, 5 micrograms <1% 57 $5K
0296T <1% 142 $5K
84153 <1% 300 $5K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,088 $5K
90715 <1% 166 $5K
84156 <1% 1,423 $5K
83525 <1% 456 $4K
85018 <1% 2,315 $4K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 1,650 $4K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,498 $4K
86200 <1% 358 $4K
71101 <1% 38 $4K
84436 <1% 721 $4K
J1756 Injection, iron sucrose, 1 mg <1% 61 $4K
87046 <1% 310 $4K
J3360 Injection, diazepam, up to 5 mg <1% 220 $4K
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 780 $4K
70544 <1% 14 $4K
95909 <1% 15 $4K
93975 <1% 12 $4K
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 1,058 $4K
29581 <1% 144 $4K
82140 <1% 307 $3K
J2060 Injection, lorazepam, 2 mg <1% 2,528 $3K
80069 <1% 547 $3K
82652 <1% 126 $3K
C1819 Surgical tissue localization and excision device (implantable) <1% 14 $3K
36600 <1% 190 $3K
72146 <1% 14 $3K
G0379 Direct admission of patient for hospital observation care <1% 14 $3K
82803 <1% 161 $3K
97166 <1% 192 $3K
87807 <1% 218 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 275 $3K
72050 <1% 28 $3K
76942 <1% 71 $3K
86304 <1% 77 $3K
95819 <1% 15 $3K
82977 <1% 451 $3K
94761 <1% 374 $3K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 262 $3K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 37 $3K
82785 <1% 170 $3K
J1453 Injection, fosaprepitant, 1 mg <1% 64 $3K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 536 $3K
82172 <1% 167 $3K
84425 <1% 144 $3K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 698 $2K
86308 <1% 542 $2K
82105 <1% 143 $2K
87109 <1% 101 $2K
87210 <1% 497 $2K
73140 <1% 38 $2K
92610 <1% 53 $2K
82375 <1% 242 $2K
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes <1% 49 $2K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 31 $2K
97010 <1% 247 $2K
87045 <1% 288 $2K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 783 $2K
86481 <1% 24 $2K
72114 <1% 13 $2K
93242 <1% 57 $2K
87220 <1% 455 $2K
86146 <1% 34 $2K
10060 <1% 15 $2K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 84 $2K
86160 <1% 95 $2K
J0592 Injection, buprenorphine hydrochloride, 0.1 mg <1% 189 $2K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,640 $2K
86664 <1% 116 $2K
96040 <1% 63 $2K
82024 <1% 37 $2K
81002 <1% 454 $2K
81596 <1% 28 $2K
J3480 Injection, potassium chloride, per 2 meq <1% 311 $2K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 53 $2K
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml <1% 78 $2K
86769 <1% 48 $2K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 294 $2K
85045 <1% 479 $2K
76882 <1% 12 $2K
82952 <1% 462 $1K
83010 <1% 136 $1K
86037 <1% 50 $1K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 77 $1K
86381 <1% 65 $1K
0012A <1% 63 $1K
83050 <1% 223 $1K
86677 <1% 27 $1K
86430 <1% 210 $1K
87209 <1% 64 $1K
86870 <1% 55 $1K
86663 <1% 87 $1K
84134 <1% 99 $1K
73090 <1% 17 $1K
82103 <1% 73 $1K
82010 <1% 166 $1K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 116 $981.39
J9045 Injection, carboplatin, 50 mg <1% 32 $965.78
84703 <1% 128 $941.33
83721 <1% 109 $919.09
86015 <1% 78 $825.54
84295 <1% 200 $793.66
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 43 $790.92
86618 <1% 29 $741.59
86923 <1% 24 $721.84
J2404 Injection, nicardipine, 0.1 mg <1% 239 $696.43
84207 <1% 29 $680.98
81050 <1% 162 $594.39
83883 <1% 39 $578.20
85613 <1% 49 $577.69
0011A <1% 69 $557.46
88312 <1% 21 $548.61
87177 <1% 58 $524.30
97802 <1% 65 $522.17
93270 <1% 12 $504.90
82164 <1% 34 $475.52
97803 <1% 43 $469.46
86707 <1% 44 $451.23
J1596 Injection, glycopyrrolate, 0.1 mg <1% 108 $449.42
87350 <1% 43 $438.14
J1940 Injection, furosemide, up to 20 mg <1% 161 $413.03
83993 <1% 17 $412.31
82270 <1% 117 $388.16
82378 <1% 29 $382.37
90686 <1% 12 $382.01
J1171 Injection, hydromorphone, 0.1 mg <1% 123 $380.36
87102 <1% 59 $355.71
82465 <1% 96 $353.65
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 229 $334.00
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 36 $333.21
J0360 Injection, hydralazine hcl, up to 20 mg <1% 68 $321.75
G0008 Administration of influenza virus vaccine <1% 27 $315.72
86705 <1% 31 $306.02
84155 <1% 129 $298.44
0004A <1% 15 $284.00
84681 <1% 12 $249.72
81015 <1% 66 $248.79
85598 <1% 16 $220.34
87116 <1% 33 $216.00
87206 <1% 70 $211.20
84478 <1% 35 $188.07
82085 <1% 26 $186.14
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 361 $175.16
80164 <1% 13 $167.20
87449 <1% 15 $157.80
85670 <1% 32 $156.71
C1755 Catheter, intraspinal <1% 12 $134.37
86362 <1% 13 $132.55
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 491 $132.36
85007 <1% 40 $119.82
86141 <1% 13 $116.55
94760 <1% 18 $114.72
J2720 Injection, protamine sulfate, per 10 mg <1% 19 $112.90
87075 <1% 15 $101.44
99499 <1% 155 $97.89
J1030 Injection, methylprednisolone acetate, 40 mg <1% 15 $89.59
80178 <1% 12 $83.25
J2305 Injection, nitroglycerin, 5 mg <1% 17 $74.64
87185 <1% 14 $70.32
82310 <1% 21 $67.08
J1805 Injection, esmolol hydrochloride, 10 mg <1% 34 $58.60
J1953 Injection, levetiracetam, 10 mg <1% 17 $55.70
J2004 Injection, lidocaine hcl with epinephrine, 1 mg <1% 41 $53.46
85732 <1% 12 $37.21
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 28 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCARRICO, RICHARD (CFO)
Same official

Other billing entities under CARRICO, RICHARD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.